|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.920 AUD | +0.51% |
|
-5.43% | -8.78% |
| Oct. 24 | Challenger Limited - Shareholder/Analyst Call | |
| Oct. 23 | Challenger on Pace Towards Rebalancing of Books, Jarden Research Says | MT |
| Capitalization | 4.03B 2.57B 2.44B 2.26B 2.01B 3.63B 218B 28.18B 10.4B 89.39B 9.63B 9.42B 390B | P/E ratio 2025 * |
10.2x | P/E ratio 2026 * | 9.13x |
|---|---|---|---|---|---|
| Enterprise value | 4.96B 3.16B 3.01B 2.79B 2.48B 4.48B 268B 34.73B 12.82B 110B 11.87B 11.62B 481B | EV / Sales 2025 * |
4.95x | EV / Sales 2026 * | 4.63x |
| Free-Float |
75.08% | Yield 2025 * |
4.84% | Yield 2026 * | 5.16% |
More valuation ratios
* Estimated data
More news
Last Transcript: Challenger Limited
More recommendations
More press releases
More news
| 1 day | +0.51% | ||
| 1 week | -3.43% | ||
| Current month | -4.82% | ||
| 1 month | -3.90% | ||
| 3 months | -3.58% | ||
| 6 months | -11.38% | ||
| Current year | -8.78% |
1 week
5.85
6.26
1 month
5.856.39
Current year
5.857.57
1 year
5.857.57
3 years
5.477.83
5 years
2.8210.43
10 years
2.8214.42
| Director | Title | Age | Since |
|---|---|---|---|
Nick Hamilton
CEO | Chief Executive Officer | - | 2021-12-31 |
Alexandra Bell
DFI | Director of Finance/CFO | - | 2022-11-30 |
Anton Kapel
PRN | Corporate Officer/Principal | - | 2022-05-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 2012-10-07 | |
| Director/Board Member | 59 | 2017-12-05 | |
John Green
BRD | Director/Board Member | 71 | 2017-12-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 10 M€ | -3.35% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.51% | -3.43% | -1.82% | -10.57% | 2.57B | ||
| -1.91% | +1.45% | +58.11% | +15.79% | 142B | ||
| -1.94% | +1.13% | -8.50% | -28.39% | 82.37B | ||
| -0.99% | -3.35% | +21.77% | - | 70.67B | ||
| +0.55% | +1.21% | +52.85% | +40.32% | 38.6B | ||
| +0.13% | +0.52% | +15.53% | +73.52% | 31.05B | ||
| -0.39% | +0.24% | -0.30% | +22.71% | 17.26B | ||
| +0.21% | -2.40% | -5.63% | -5.89% | 16.06B | ||
| +0.65% | +1.15% | +21.40% | -4.42% | 12.31B | ||
| +2.11% | +2.89% | +29.38% | +22.40% | 11.6B | ||
| Average | -0.11% | -0.17% | +18.28% | +13.94% | 42.45B | |
| Weighted average by Cap. | -1.05% | +1.08% | +28.54% | +11.92% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1B 638M 608M 563M 501M 904M 54.18B 7.01B 2.59B 22.25B 2.4B 2.35B 97.08B | 1.06B 677M 645M 597M 531M 959M 57.47B 7.44B 2.75B 23.6B 2.54B 2.49B 103B |
| Net income | 450M 287M 273M 253M 225M 406M 24.31B 3.15B 1.16B 9.98B 1.08B 1.05B 43.57B | 487M 310M 295M 274M 243M 439M 26.32B 3.41B 1.26B 10.81B 1.16B 1.14B 47.17B |
| Net Debt | 937M 597M 568M 527M 468M 846M 50.67B 6.56B 2.42B 20.8B 2.24B 2.19B 90.79B | 898M 572M 545M 505M 449M 811M 48.57B 6.29B 2.32B 19.94B 2.15B 2.1B 87.03B |
More financial data
* Estimated data
Employees
676
Sector
Life & Health Insurance
Calendar
2025-02-17
- Q2 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-11 | 5.920 $ | +0.51% | 1,578,404 |
| 24-12-10 | 5.890 $ | -1.51% | 1,426,933 |
| 24-12-09 | 5.980 $ | -1.16% | 1,494,137 |
| 24-12-06 | 6.050 $ | -2.42% | 1,722,020 |
| 24-12-05 | 6.200 $ | +1.14% | 1,835,909 |
Delayed Quote Australian S.E., December 11, 2024 at 12:10 am EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
5.890AUD
Average target price
7.798AUD
Spread / Average Target
+32.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CGF Stock